Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

AUTOR(ES)

Melander, Hans

FONTE

BMJ Publishing Group Ltd.

RESUMO

Objectives To investigate the relative impact on publication bias caused by multiple publication, selective publication, and selective reporting in studies sponsored by pharmaceutical companies.

Documentos Relacionados

• Rheumatism in industry: a review
• Lean philosophy and its applications in the service industry: a review of the current knowledge
• Psychiatric Advice in Industry: I *
• Qualification of analytical instruments for use in the pharmaceutical industry: A scientific approach
• Academic scientists and the pharmaceutical industry: cooperative research in twentieth-century America